Nektar Therapeutics
NASDAQ:NKTR

Watchlist Manager
Nektar Therapeutics Logo
Nektar Therapeutics
NASDAQ:NKTR
Watchlist
Price: 1.17 USD -8.59% Market Closed
Market Cap: 215.4m USD
Have any thoughts about
Nektar Therapeutics?
Write Note

Nektar Therapeutics
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Nektar Therapeutics
Current Portion of Long-Term Debt Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Nektar Therapeutics
NASDAQ:NKTR
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Current Portion of Long-Term Debt
$2.5B
CAGR 3-Years
0%
CAGR 5-Years
6%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Current Portion of Long-Term Debt
$873m
CAGR 3-Years
-43%
CAGR 5-Years
N/A
CAGR 10-Years
8%
Pfizer Inc
NYSE:PFE
Current Portion of Long-Term Debt
$3.7B
CAGR 3-Years
12%
CAGR 5-Years
9%
CAGR 10-Years
-4%
Merck & Co Inc
NYSE:MRK
Current Portion of Long-Term Debt
$3.1B
CAGR 3-Years
-4%
CAGR 5-Years
-2%
CAGR 10-Years
-10%
Eli Lilly and Co
NYSE:LLY
Current Portion of Long-Term Debt
$2.1B
CAGR 3-Years
10%
CAGR 5-Years
6%
CAGR 10-Years
21%

See Also

Back to Top